It is unknown if there was a deterioration in patient health.We have asked the customer multiple times with no response.There is no indication of a malfunction with a ventana medical systems instrument or assay.The alk package insert 790-4796 (b)(4) and interpretation guide 790-4796 (b)(4) mandate the use of system controls run with all patient samples.The package insert specifically calls out excessive non-specific background staining of glandular epithelial cells, muscle, or lymphoid tissue that interferes with scoring as unacceptable and instructs users that if the positive or negative tissue controls fail to demonstrate appropriate staining or demonstrate a change in clinical diagnostic interpretation, any results with the test specimens should be considered invalid.In addition, the alk interpretation guide provides image examples of unacceptable background staining.Use of tissue controls is also mandated by global quality assurance organizations and quality control guidelines including the clinical laboratory improvement amendments clia regulations.This is the initial and final report.
|